CALB2 and Colorectal Cancer: How CALB2 Affects 5-FU Sensitivity
Author Information
Author(s): Leanne Stevenson, Wendy L. Allen, Irina Proutski, Gail Stewart, Louise Johnston, Karen McCloskey, Peter M. Wilson, Daniel B. Longley, Patrick G. Johnston
Primary Institution: Queen's University Belfast, Belfast, Northern Ireland
Hypothesis
The study investigates the role of Calbindin 2 (CALB2) in regulating the response of colorectal cancer (CRC) cells to 5-Fluorouracil (5-FU).
Conclusion
CALB2 is involved in apoptosis induction through the intrinsic mitochondrial pathway, and its down-regulation may represent a mechanism of resistance to 5-FU in colorectal cancer cells.
Supporting Evidence
- CALB2 expression was down-regulated in CRC cell lines following 5-FU treatment.
- 5-FU-induced apoptosis was significantly reduced in CALB2-silenced CRC cell lines.
- CALB2 translocated to the mitochondria following 5-FU treatment.
- Co-silencing of XIAP overcame 5-FU resistance in CALB2-silenced cells.
- The study identified pathways associated with 5-FU resistance, including calcium signaling and apoptosis.
Takeaway
CALB2 helps cancer cells die when treated with a drug called 5-FU, and if CALB2 is turned off, the cancer cells can survive the treatment better.
Methodology
The study used real-time RT-PCR, Western blot analysis, and flow cytometry to assess CALB2 expression and apoptosis in CRC cell lines treated with 5-FU.
Limitations
The study primarily focuses on in vitro models, which may not fully replicate the complexity of human tumors.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website